Check out our most popular compounded medications! Get Started
Morphine Sulfate 60 mg Slow Release Capsules are compounded with Methocel E4M, a controlled-release polymer. This formulation is designed to gradually release the active ingredient over an extended period, providing sustained therapeutic effects. This reduces the need for frequent dosing and improves patient compliance. These capsules are used to manage various types of pain including chronic, cancer, postoperative, neuropathic, and arthritis pain.
Licensed to fill prescriptions for patients in RI, MA, CT, NY, NJ, NH, FL and ME.
Prescriber? Sign in or create an account for prescription details and order forms.
Morphine Sulfate 60 mg Slow Release Capsules are a potent, long-acting opioid analgesic designed to manage moderate to severe pain. This formulation is specifically engineered to provide a steady, consistent release of the active ingredient, Morphine Sulfate, over an extended period of time.
The capsules are formulated with Methocel E4M, a type of controlled-release polymer. This polymer is designed to gradually release the encapsulated medication over time, offering sustained therapeutic effects. This reduces the need for frequent dosing and improves patient compliance, particularly for medications requiring a controlled and prolonged release profile.
However, this formulation is not recommended for patients with acute pain, as it may not provide immediate or adequate pain relief. It is also important for patients to be aware that Morphine Sulfate 60 mg Slow Release Capsules may cause side effects such as drowsiness, dizziness, and confusion. As such, patients should avoid driving or operating machinery while taking this medication.
Patients should also be aware of the potential for dependency with this medication. It is important to take Morphine Sulfate 60 mg Slow Release Capsules only as prescribed and not for a longer duration than recommended by a healthcare provider.
For healthcare providers, it is crucial to note that Morphine Sulfate 60 mg Slow Release Capsules may cause respiratory depression. Therefore, it should be used with caution in patients with respiratory conditions. Additionally, due to the potential for dependency, this medication should be prescribed for the shortest duration necessary to manage the patient's pain effectively.
If you have any questions or concerns about Morphine Sulfate 60 mg Slow Release Capsules, please do not hesitate to contact us at Bayview Pharmacy. We are here to assist you with your medication needs.
Morphine Sulfate 60 mg Slow Release Capsules are a potent analgesic medication indicated for the management of moderate to severe pain. This particular formulation utilizes Methocel E4M, a type of controlled-release polymer, which is designed to gradually release the encapsulated morphine sulfate over an extended period of time. This slow-release mechanism offers sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance, particularly beneficial for medications requiring a controlled and prolonged release profile.
It is crucial to note that Morphine Sulfate 60 mg Slow Release Capsules should not be administered to patients with known hypersensitivity to morphine or other opioids, or in patients with significant respiratory depression. Regular monitoring for signs of respiratory depression, sedation, and hypotension is recommended. Additionally, vigilance for signs of opioid abuse or misuse, including drug-seeking behavior, is advised.
Patients are strongly advised to abstain from alcohol and other CNS depressants while on this medication. Activities requiring mental alertness, such as driving or operating machinery, should be avoided until the patient is aware of how this medication affects them. In the event of any signs of an allergic reaction, such as rash, hives, or difficulty breathing, patients should seek immediate medical attention.
Morphine Sulfate 60 mg Slow Release Capsules are a potent, extended-release analgesic formulation designed to manage moderate to severe pain. These capsules are formulated with Methocel E4M, a type of controlled-release polymer, which ensures the gradual release of the encapsulated medication over an extended period. This slow-release mechanism offers sustained therapeutic effects, reducing the need for frequent dosing and enhancing patient compliance, particularly for those requiring a controlled and prolonged release profile.
The capsules are administered orally, typically once a day, and should be consumed with food to ensure optimal absorption. It is crucial to adhere to the prescribed dosage and frequency as directed by your healthcare provider. Overdosing or underdosing, as well as taking the medication more frequently than advised, can lead to adverse effects or diminished efficacy.
While primarily used for pain management, Morphine Sulfate 60 mg Slow Release Capsules can also be employed to alleviate other conditions such as chronic pain, cancer-related pain, and post-operative pain. However, it is essential to discuss with your healthcare provider the potential risks and benefits of using this medication for your specific condition.
If you have any queries or concerns regarding Morphine Sulfate 60 mg Slow Release Capsules, do not hesitate to reach out. We are committed to helping you understand the workings of this medication and how it can assist you in managing your pain effectively.
Morphine Sulfate 60 mg Slow Release Capsules are a compounded formulation designed to provide sustained pain relief over an extended period. These capsules are formulated with Methocel E4M, a type of controlled-release polymer, which allows for the gradual release of the active ingredient, morphine sulfate. This slow-release mechanism offers prolonged therapeutic effects, reduces the need for frequent dosing, and improves patient compliance, particularly for medications requiring a controlled and extended release profile.
These capsules can be used to manage various types of pain, including musculoskeletal pain, fibromyalgia, and headaches. Additionally, Morphine Sulfate 60 mg Slow Release Capsules can be used to alleviate opioid-induced constipation and to reduce the severity of withdrawal symptoms in patients with opioid dependence.
However, caution should be exercised when using Morphine Sulfate 60 mg Slow Release Capsules in patients with renal or hepatic impairment, as well as in patients with a history of substance abuse. Close monitoring for signs of respiratory depression, sedation, and constipation is recommended. If you have any questions about the use of Morphine Sulfate 60 mg Slow Release Capsules for any of these indications, please do not hesitate to reach out for further information.
Morphine Sulfate 60 mg Slow Release Capsules is a medication formulated with Methocel E4M, a type of controlled-release polymer. This formulation is designed to release the encapsulated medication gradually over an extended period of time.
The controlled-release polymer, Methocel E4M, is designed to release the medication gradually over an extended period of time. This offers sustained therapeutic effects, reduces dosing frequency, and improves patient compliance for medications requiring a controlled and prolonged release profile.
A slow-release formulation offers several benefits. It provides sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance, particularly for medications that require a controlled and prolonged release profile.
As this is a slow-release formulation, the frequency of dosing is typically reduced. However, the exact dosing schedule should be determined by your healthcare provider based on your specific medical condition and response to therapy.
'Improved patient compliance' means that patients are more likely to take the medication as prescribed. This is because the slow-release formulation reduces the frequency of dosing, making it easier for patients to adhere to their medication regimen.
Methocel E4M is a type of controlled-release polymer used in the formulation of this medication. It is designed to gradually release the encapsulated medication over an extended period of time, providing sustained therapeutic effects.
No, you should not break or crush the capsules. Doing so can release all of the drug at once, increasing the risk of morphine overdose.
If you miss a dose, take it as soon as you remember. If it is near the time of the next dose, skip the missed dose. Take your next dose at the regular time. Do not double the dose to catch up.
Common side effects may include drowsiness, dizziness, constipation, or sweating. If any of these effects persist or worsen, tell your doctor or pharmacist promptly.
No, you should avoid alcohol while taking this medication as it can increase the risk of serious side effects such as severe drowsiness, dizziness, and difficulty breathing.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
This preparation is a controlled substance. Additional prescribing, refill, and shipping restrictions apply, and the states Bayview can dispense it to are narrower than for non-controlled preparations.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NY, NJ, NH, FL, and ME. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth
